Evidence map›Paper›PMID 40144269›Full record

ArticleJHLT open2024

Cardiac allograft vasculopathy outcomes among donation after circulatory death heart transplant recipients.

Antoinette S Birs, Quan M Bui, Yan Gernhofer, Antonio Duran, Lucas Keyt, Kevin Paternostro, Jeffrey Ding, Eric Adler, Lawrence Ang, Marcus A Urey and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antoinette S BirsDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Quan M BuiDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Yan GernhoferUniversity of the Incarnate Word School of Osteopathic Medicine, San Antonio, Texas.
Antonio DuranDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Lucas KeytUniversity of California San Diego School of Medicine, La Jolla, California.
Kevin PaternostroUniversity of California San Diego School of Medicine, La Jolla, California.
Jeffrey DingUniversity of California San Diego School of Medicine, La Jolla, California.
Eric AdlerDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Lawrence AngDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Marcus A UreyDivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
Mark J KearnsDivision of Cardiovascular and Thoracic Surgery, Department of Surgery, University of California, San Diego, La Jolla, California.
Nicholas WetterstenDivision of Cardiovascular Medicine, San Diego Veterans Affairs Medical Center, San Diego, California.
Victor PretoriusDivision of Cardiovascular and Thoracic Surgery, Department of Surgery, University of California, San Diego, La Jolla, California.

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
CSRD VA IK2 CX002105NHLBI NIH HHS T32 HL007444
6 · The paper itself

Abstract

Background: Cardiac allograft vasculopathy (CAV) accounts for significant long-term morbidity and mortality in heart transplant recipients; limited data exist for donation after circulatory death (DCD). Intravascular ultrasound (IVUS) assessment is a gold standard for early diagnosis of CAV and has strong prognostic power. Methods: We evaluated all consecutive circulatory and brain death heart transplant recipients from January 2020 to March 2022. Patients were followed for need for percutaneous coronary intervention (PCI), development of severe allograft vasculopathy, or death. Among 143 heart transplant recipients, 39 received circulatory death and 104 received brain death hearts. Results: Baseline characteristics were similar between groups: median age (56.3 vs 53.7 years, Conclusion: In DCD heart transplant recipients, circulatory death donors did not have a significantly higher risk for coronary allograft vasculopathy by IVUS or related complications at 1 year following transplantation.

Indexed as

cardiac allograft vasculopathydonation after circulatory deathheart transplantationheart transplant outcomesintravascular ultrasound

Identifiers

PMID40144269
PMCPMC11935384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.